AI Article Synopsis

  • The study tested whether the Glasgow Coma Scale-Pupils (GCS-P) score is a better predictor of mortality than the traditional Glasgow Coma Scale (GCS) in patients with traumatic brain injury (TBI).
  • Researchers conducted a prospective study with 573 adult TBI patients, analyzing their GCS and GCS-P scores upon ICU admission along with various clinical data to determine outcomes.
  • Results showed that both GCS and GCS-P had similar predictive power for mortality and functional outcomes at discharge and 6 months later, indicating that while GCS-P is effective, it is not superior to GCS in predicting these outcomes.

Article Abstract

Objectives: Glasgow Coma Scale-Pupils (GCS-P) score has been found to be strongly related to in-hospital mortality in retrospective studies. We hypothesized that GCS-P would be better prognosticator than Glasgow Coma Scale (GCS) in patients with traumatic brain injury (TBI).

Methods: In this prospective, multicentric, observational study, GCS and GCS-P scores were noted in adult TBI patients at ICU admission. Demographic variables, relevant clinical history, clinical/radiological findings and ICU complications were also noted. Extended Glasgow Outcome scale was noted at hospital discharge and at 6 months post-injury. Logistic regression analysis was carried out to estimate the odds for poor outcome adjusted for covariates. Sensitivity, specificity, area under curve (AUC) and odds ratio are reported for poor outcome at estimated cutoff point.

Results: A total of 573 patients were included in this study. The predictive power for mortality, shown by the AUC, was 0.81 [95% CI: 0.77-0.85] for GCS and 0.81 [95% CI: 0.77-0.86] for GCS-P score, both being comparable. Similarly, the predictive ability for outcome at discharge and 6 months, the AUC-ROC for both GCS and GCS-P were comparable.

Conclusions: GCS-P is a good predictor of mortality and poor outcome. However, the predictive performance of GCS and GCS-P for in-hospital mortality and functional outcome at discharge and at 6 months remains comparable.

Download full-text PDF

Source
http://dx.doi.org/10.1080/02699052.2023.2227943DOI Listing

Publication Analysis

Top Keywords

gcs gcs-p
12
discharge 6 months
12
poor outcome
12
traumatic brain
8
glasgow coma
8
gcs-p score
8
in-hospital mortality
8
081 [95%
8
outcome discharge
8
gcs-p
7

Similar Publications

Background: Traumatic Brain Injury (TBI) is a leading cause of hospitalization and disability in young and middle-aged adults. This study aims to survey the efficacy of oral modafinil, a low-side-effect central nervous system stimulant, in the enhancement of consciousness recovery in moderate to severe TBI patients in the ICUs of a referral trauma center.

Materials And Methods: All ICU patients meeting inclusion criteria between April 2021 and April 2023 were screened.

View Article and Find Full Text PDF

To compare the incremental prognostic value of pupillary reactivity captured as part of the Glasgow Coma Scale-Pupils (GCS-P) score or added as separate variable to the GCS+P, in traumatic brain injury (TBI). We analyzed patients enrolled between 2014 and 2018 in the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI, = 3521) and the Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI, = 1439) cohorts. Logistic regression was utilized to quantify the prognostic performances of GCS-P (GCS minus number of unreactive pupils) and GCS+P versus GCS alone according to Nagelkerke's .

View Article and Find Full Text PDF

Prognostic value of thrombocytopenia during hospitalizations in intracerebral hemorrhage patients.

Front Neurol

November 2024

Department of Neurosurgery, Nanchong Central Hospital/The Second Clinical Medical College, North Sichuan Medical College, Nanchong, China.

Background: The thrombocytopenia influences prognoses of critically ill patients. There are few studies exploring the prognostic value of thrombocytopenia among ICH patients. We perform this study to explore the correlation between thrombocytopenia at different timepoints of hospitalizations and mortality of ICH.

View Article and Find Full Text PDF

Clinicopathological analysis of claudin 18.2 focusing on intratumoral heterogeneity and survival in patients with metastatic or unresectable gastric cancer.

ESMO Open

December 2024

Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea; Department of Interdisciplinary Program in Cancer Biology, Seoul National University College of Medicine, Seoul, Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. Electronic address:

Background: This study aimed to investigate the prevalence of claudin 18.2 (CLDN18.2) positivity, with a particular focus on intratumoral heterogeneity, and its association with clinicopathological features in metastatic or unresectable gastric cancer (GC).

View Article and Find Full Text PDF
Article Synopsis
  • * Five experimental groups were created to assess different conditions, measuring parameters like apoptosis rates, oxidative stress indicators (GSH, GSSG, ROS), and key protein levels related to cellular response.
  • * Results showed that HUC-MSCs decreased apoptosis rates in cancer cells and improved antioxidant levels by activating the ERK-Nrf2-HO-1 pathway, suggesting that they might enhance the cancer cells' resistance to oxidative damage.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!